Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Prins

Showing results (161-170 of 560) with videos related to

Pageof 56
Sort By:
Preventive Medicine Reports|November 29, 2017
The ability of triggers to retrospectively predict potentially preventable adverse events in a sample of deceased patientsDorthe O Klein, Roger J M W Rennenberg, Richard P Koopmans, et al.
BMC Health Services Research|January 10, 2019
The Harvard medical practice study trigger system performance in deceased patientsDorthe O Klein, Roger J M W Rennenberg, Richard P Koopmans, et al.
Thrombosis and Haemostasis|December 29, 2000
Duration of oral anticoagulant treatment in patients with venous thromboembolism and a deficiency of antithrombin, protein C or protein S--a decision analysisA G van den Belt, B A Hutten, M H Prins, et al.
Annals of Internal Medicine|January 1, 1995
Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysisP S Wells, A W Lensing, B L Davidson, et al.
British Journal of Pharmacology|September 2, 2004
5-HT7 receptor efficacy distribution throughout the canine stomachPieter Janssen, Nicolaas H Prins, Pieter J Peeters, et al.
Lancet (London, England)|December 2, 2011
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trialHarry R Büller, Alex S Gallus, Gerard Pillion, et al.
BMC Family Practice|August 5, 2016
Comparison of 10 single and stepped methods to identify frail older persons in primary care: diagnostic and prognostic accuracyFleur L Sutorius, Emiel O Hoogendijk, Bernard A H Prins, et al.
Journal of Thrombosis and Haemostasis : JTH|April 19, 2007
Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosisP Prandoni, B A Hutten, C J J van Dongen, et al.
Thrombosis Research|May 19, 2015
Residual vein thrombosis and the risk of subsequent serious complicationsPaolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.
Archives of Internal Medicine|December 10, 2003
Recurrent thromboembolism after treatment with vitamin K antagonistsCarlo J van Dongen, Roel Vink, Barbara A Hutten, et al.
Pageof 56

Showing results (161-170 of 560) with videos related to

Sort By:
Pageof 56
Preventive Medicine Reports|November 29, 2017
The ability of triggers to retrospectively predict potentially preventable adverse events in a sample of deceased patientsDorthe O Klein, Roger J M W Rennenberg, Richard P Koopmans, et al.
BMC Health Services Research|January 10, 2019
The Harvard medical practice study trigger system performance in deceased patientsDorthe O Klein, Roger J M W Rennenberg, Richard P Koopmans, et al.
Thrombosis and Haemostasis|December 29, 2000
Duration of oral anticoagulant treatment in patients with venous thromboembolism and a deficiency of antithrombin, protein C or protein S--a decision analysisA G van den Belt, B A Hutten, M H Prins, et al.
Annals of Internal Medicine|January 1, 1995
Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysisP S Wells, A W Lensing, B L Davidson, et al.
British Journal of Pharmacology|September 2, 2004
5-HT7 receptor efficacy distribution throughout the canine stomachPieter Janssen, Nicolaas H Prins, Pieter J Peeters, et al.
Lancet (London, England)|December 2, 2011
Enoxaparin followed by once-weekly idrabiotaparinux versus enoxaparin plus warfarin for patients with acute symptomatic pulmonary embolism: a randomised, double-blind, double-dummy, non-inferiority trialHarry R Büller, Alex S Gallus, Gerard Pillion, et al.
BMC Family Practice|August 5, 2016
Comparison of 10 single and stepped methods to identify frail older persons in primary care: diagnostic and prognostic accuracyFleur L Sutorius, Emiel O Hoogendijk, Bernard A H Prins, et al.
Journal of Thrombosis and Haemostasis : JTH|April 19, 2007
Quality of oral anticoagulant treatment and risk of subsequent recurrent thromboembolism in patients with deep vein thrombosisP Prandoni, B A Hutten, C J J van Dongen, et al.
Thrombosis Research|May 19, 2015
Residual vein thrombosis and the risk of subsequent serious complicationsPaolo Prandoni, Anthonie W A Lensing, Martin H Prins, et al.
Archives of Internal Medicine|December 10, 2003
Recurrent thromboembolism after treatment with vitamin K antagonistsCarlo J van Dongen, Roel Vink, Barbara A Hutten, et al.
Pageof 56